Core Molding Technologies Announces Timing of First Quarter Fiscal Year 2024 Results
COLUMBUS, Ohio, April 18, 2024 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the […]
TSX News -
Canacol Energy Ltd. Announces New Gas Discovery at Chontaduro 1
CALGARY, Alberta, April 18, 2024 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased […]
TSX News -
Dundee Precious Metals Annual Meeting of Shareholders to be Held May 8, 2024
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces its Annual […]
Gray Renews InvestigateTV+ For 2024-2025 Season
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray” or the “Company”) (NYSE: GTN) announced today that its […]
ABM Honored as a 2024 VETS Indexes 3 Star Employer
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of integrated facility services, infrastructure solutions, […]
BiomX Announces the Appointment of Susan Blum to its Board of Directors
CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the […]
Olaplex Holdings, Inc. to Report First Quarter Fiscal 2024 Financial Results on May 2nd
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report first […]
CoreCard Corporation Schedules First Quarter 2024 Earnings Release and Conference Call
NORCROSS, Ga., April 18, 2024 (GLOBE NEWSWIRE) — CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions […]
JD.com Announces Updates of Its Share Repurchase Program
BEIJING, April 18, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) […]
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- […]
